Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study.
Eva Kirmeier, Lars I Eriksson, Heidrun Lewald...
https://pubmed.ncbi.nlm.nih.gov/30224322/Actively Recruiting
Led by Tamas Vegh, MD · Updated on 2024-11-15
46
Participants Needed
2
Research Sites
N/A
Total Duration
Researchers are evaluating how well the TetraGraph device measures muscle responses at two sites on the arm the adductor pollicis thumb and the abductor digiti minimi fifth digit. The study focuses on the timing of muscle response during the onset and recovery from neuromuscular blockade caused by rocuronium and reversed by sugammadex. This is important because residual muscle weakness after surgery can cause complications, and monitoring this accurately helps improve patient safety. In this observational study, patients undergoing elective surgeries receive neuromuscular blocking agents including rocuronium followed by reversal with sugammadex. Two TetraGraph devices are placed on different muscles to monitor electrical activity through electromyography EMG. Measurements are taken frequently from the start of neuromuscular blockade until recovery, including every 20 seconds after sugammadex administration until the patient is extubated. Participants are monitored continuously during surgery with standard equipment and the TetraGraph devices, with recordings taken every 15 seconds during baseline and every 5 minutes during surgery. After surgery, assessments continue until muscle function recovers to a defined level. Researchers measure the rate of recovery from blockade and the incidence of residual muscle weakness one hour after extubation. The study aims to improve understanding of muscle site sensitivity and monitoring techniques in surgical patients.
CONDITIONS
Comparison of Adductor Pollicis and Abductor Digiti Minimi Muscles (Thumb Vs. Fifth Digit) As Sites for Neuromuscular Monitoring with Electromyography
G
György NAGY, MD
E
Erzsébet Igbonu-Nagy, BSC
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Tamas Vegh, MD
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration of surgery, typically several hours
Participants undergo neuromuscular monitoring using two devices placed on the hand and fifth digit to measure muscle responses during anesthesia and surgery.
1 intraoperative monitoring session
Duration - Up to 1 hour after extubation
Participants are monitored after surgery to assess neuromuscular recovery and detect any residual weakness.
Continuous monitoring for up to 1 hour post-extubation
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Eva Kirmeier, Lars I Eriksson, Heidrun Lewald...
https://pubmed.ncbi.nlm.nih.gov/30224322/Thomas Ledowski, Samuel Hillyard, Brendan O'Dea...
https://pubmed.ncbi.nlm.nih.gov/23716766/Frank Herbstreit, Jürgen Peters, Matthias Eikermann
https://pubmed.ncbi.nlm.nih.gov/19417617/T Fuchs-Buder, C Claudius, L T Skovgaard...
https://pubmed.ncbi.nlm.nih.gov/17635389/Manfred Blobner, Jennifer M Hunter, Claude Meistelman...
https://pubmed.ncbi.nlm.nih.gov/31607388/Matthias Eikermann, Florian M Vogt, Frank Herbstreit...
https://pubmed.ncbi.nlm.nih.gov/17023729/Glenn S Murphy, Joseph W Szokol, Jesse H Marymont...
https://pubmed.ncbi.nlm.nih.gov/18635478/Réka Nemes, Béla Fülesdi, Adrienn Pongrácz...
https://pubmed.ncbi.nlm.nih.gov/28030444/E Sundman, H Witt, R Olsson...
https://pubmed.ncbi.nlm.nih.gov/10754616/Mohamed Naguib, Sorin J Brull, Aaron F Kopman...
https://pubmed.ncbi.nlm.nih.gov/29200077/Tamas Vegh, MD
Lead Sponsor